Rituximab in combination with CHOP improves survival in elderly patients with aggressive non-Hodgkin's lymphoma

被引：7
|
作者：
Coiffier, B [1 ]
机构：
[1] Ctr Hosp Lyon Sud, Hematol Serv, Lyon, France
来源：
TUMORI | 2002年 / 88卷 / 01期
关键词：
D O I：
10.1177/030089160208800108
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S26 / S28
页数：3
相关论文
共 50 条
  • [1] Rituximab in combination with CHOP improves survival in elderly patients with aggressive non-Hodgkin's lymphoma
    Coiffier, B
    SEMINARS IN ONCOLOGY, 2002, 29 (02) : 18 - 22
  • [2] Chemoimmunothery with combination of Rituximab, GMCSF and CHOP in patients with previously untreated aggressive non-Hodgkin's lymphoma.
    Venugopal, P
    Wooldridge, J
    Yunus, F
    Adler, SS
    Shammo, JM
    Enschede, SH
    O'Brien, TM
    Means, A
    Nathan, S
    Venugopal, G
    Sokolovsky, TB
    Gregory, SA
    BLOOD, 2003, 102 (11) : 302B - 302B
  • [3] ACOD, a modified CHOP regimen for elderly patients with aggressive non-Hodgkin's lymphoma
    Santoro, P
    Martinelli, G
    Ferrucci, PF
    Mingrone, W
    Cocorocchio, E
    Conconi, A
    Peccatori, FA
    De Luzio, K
    Mazzetta, C
    Zucca, E
    Cavalli, F
    LEUKEMIA & LYMPHOMA, 2003, 44 (05) : 801 - 806
  • [4] Phase II study of rituximab in combination with CHOP chemotherapy in patients with previously untreated, aggressive non-Hodgkin's lymphoma
    Vose, JM
    Link, BK
    Grossbard, ML
    Czuczman, M
    Grillo-Lopez, A
    Gilman, P
    Lowe, A
    Kunkel, LA
    Fisher, RI
    JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (02) : 389 - 397
  • [5] Rituximab (MabThera) for aggressive non-Hodgkin's lymphoma
    不详
    EUROPEAN JOURNAL OF CANCER CARE, 2003, 12 (04) : 306 - 307
  • [6] Treatment of elderly patients with aggressive non-Hodgkin's lymphoma
    Fridrik, MA
    ONKOLOGIE, 1998, 21 (03): : 251 - 254
  • [7] Dose intensity (DI) chemotherapy improves disease free survival in elderly aggressive non-Hodgkin's lymphoma (NHL) patients treated with conventional CHOP
    Gomez, H
    Santillana, S
    Casanova, L
    Valdivia, S
    Otero, J
    Mas, L
    Vallejos, C
    EUROPEAN JOURNAL OF CANCER, 1995, 31A : 802 - 802
  • [8] Phase II study of rituximab in combination with CHOP chemotherapy and GMCSF in patients with previously untreated aggressive non-Hodgkin's lymphoma.
    Venugopal, P
    Gregory, SA
    Wooldridge, J
    Yunus, F
    Adler, S
    Shammo, J
    Enschede, S
    O'Brien, T
    Franson, P
    Porter, C
    BLOOD, 2002, 100 (11) : 314B - 314B
  • [9] Cost-effectiveness analysis of rituximab plus CHOP versus CHOP in patients with aggressive non-Hodgkin lymphoma
    Berto, P
    Morsanutto, A
    Lopatriello, S
    VALUE IN HEALTH, 2004, 7 (06) : 643 - 644
  • [10] CHOP versus CHOP plus granulocyte colony-stimulating factor in elderly patients with aggressive non-Hodgkin's lymphoma
    Alliot, C
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (21) : 4797 - 4799
12345